Euro
USD
British Pound
NULL
Product Description
LYPD3 is a structural homologue of the urokinase-type plasminogen activator receptor (uPAR or PLAUR) and contains two Ly-6 (leucocyte antigen 6)/uPAR/α-neurotoxin domains. It is a metastasis-associated membrane protein and is elevated in lung adenocarcinoma.
Biovision | P1612 | Human CellExp™ LYPD3 DataSheet
Biomolecule/Target :
Synonyms: Ly6/PLAUR Domain-Containing Protein; LYPD3; C4.4A; GPI-anchored metastasis-associated protein C4.4A homolog; Matrigel-induced gene C4 protein; MIG-C4
Alternates names: Ly6/PLAUR Domain-Containing Protein; LYPD3; C4.4A; GPI-anchored metastasis-associated protein C4.4A homolog; Matrigel-induced gene C4 protein; MIG-C4
Taglines: A metastasis-associated membrane protein
NCBI Gene ID #: 27076
NCBI Gene Symbol:
Gene Source: Human
Accession #: O95274
Recombinant: TRUE
Source: HEK293 cells
Purity by SDS-PAGE: ≥ 97% by SDS-PAGE
Assay:
Purity:
Assay #2:
Endotoxin Level: < 0.1 EU/ug of the protein as determined by LAL method
Activity (Specifications/test method):
Biological activity:
Results:
Binding Capacity:
Unit Definition:
Molecular Weight: The protein migrates as a band at 45-68 kDa in SDS-PAGE
Concentration:
Appearance: Lyophilized protein
Physical form description: Lyophilized protein
Reconstitution Instructions: Reconstitute to a concentration of 0.1-0.5 mg/ml in sterile distilled water.
Amino acid sequence: aa Leu31-His286
Handling: Centrifuge the vial prior to opening.
Usage: For Research Use Only! Not to be used in humans
